Þorvarður R. Hálfdánarson

Also affiliated with WinnMed, Mayo Clinic in Arizona, Mayo Clinic in Florida

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile

0.140Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Demographics, outcomes, and risk factors for patients (Pts) with sarcoma and COVID-19: A multi-institutional cohort analysis.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11523

Top 71%

0.140DataRank

Top 71%1 citations

Matthew Ingham, Corrie Painter, Rashmi Chugh, Jonathan C. Trent, Vivek Subbiah +15 more

Papers

Driven by 25 papers — median percentile 29. Top paper: “Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study”.

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

The Lancet(2020)10.1016/s0140-6736(20)31187-9

N/A

11.9DataRank · unranked

1804 citations

Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein, Donna R. Rivera +95 more

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

Annals of Oncology(2021)10.1016/j.annonc.2021.02.024

N/A

6.8DataRank · unranked

328 citations

Ali Raza Khaki, Trisha M. Wise‐Draper, Benjamin French, Conor Hennessy, Chih–Yuan Hsu +95 more

Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer

JAMA Network Open(2022)10.1001/jamanetworkopen.2021.49040

N/A

3.5DataRank · unranked

127 citations

Fang‐Shu Ou, Tyler Zemla, Þorvarður R. Hálfdánarson, Heinz‐Josef Lenz, Rimini Breakstone +11 more

Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors

New England Journal of Medicine(2024)10.1056/nejmoa2403991

N/A

3.0DataRank · unranked

141 citations

Susan M. Geyer, Tyler Zemla, Michael V. Knopp, Spencer C. Behr, Sydney Pulsipher +19 more

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19

JAMA Oncology(2022)10.1001/jamaoncol.2022.5357

N/A

1.5DataRank · unranked

63 citations

Chris Labaki, Punita Grover, Joy Awosika, Shuchi Gulati, Chih–Yuan Hsu +95 more

Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0941

N/A

0.740DataRank · unranked

138 citations

Solange Peters, Orestis A. Panagiotou, Dimpy P. Shah, Nicole M. Kuderer, Chih–Yuan Hsu +40 more

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

Cancer Cell(2020)10.1016/j.ccell.2020.10.022

N/A

0.529DataRank · unranked

33 citations

David M. Aboulafia, Melissa Accordino, Jared D. Acoba, Manmeet S. Ahluwalia, Syed A. Ahmad +95 more

LBA53 Alliance A021602: Phase III, double-blinded study of cabozantinib versus placebo for advanced neuroendocrine tumors (NET) after progression on prior therapy (CABINET)

Annals of Oncology(2023)10.1016/j.annonc.2023.10.047

N/A

0.500DataRank · unranked

27 citations

Susan M. Geyer, F-S. Ou, Michael V. Knopp, Spencer C. Behr, Tyler Zemla +14 more

Primary neuroendocrine tumors and primary neuroendocrine carcinomas of the liver: a proposal for a multidiscipline definition

Human Pathology(2022)10.1016/j.humpath.2022.07.001

N/A

0.385DataRank · unranked

12 citations

Sudhakar K. Venkatesh, Þorvarður R. Hálfdánarson, Patrick J. Navin, Patrick S. Kamath, Lori A. Erickson +1 more

Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States

JAMA Network Open(2022)10.1001/jamanetworkopen.2021.42046

N/A

0.373DataRank · unranked

11 citations

Tianyi Sun, David D. Chism, Narjust Duma, Julie Fu, Na Tosha Gatson +87 more

Discordant risk factors between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinoma

Endocrine Related Cancer(2025)10.1530/erc-24-0142

N/A

0.269DataRank · unranked

5 citations

Þorvarður R. Hálfdánarson, Erin E. Carlson, Kari G. Rabe, Amit Mahipal, Shounak Majumder +9 more

Demographics, outcomes, and risk factors for patients (Pts) with sarcoma and COVID-19: A multi-institutional cohort analysis.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11523

Top 71%

0.140DataRank

Top 71%1 citations

Matthew Ingham, Corrie Painter, Rashmi Chugh, Jonathan C. Trent, Vivek Subbiah +15 more

COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease

Translational Oncology(2023)10.1016/j.tranon.2023.101709

N/A

0.115DataRank · unranked

1 citations

Cassandra Hennessy, Benjamin French, Jeremy L. Warner, Matthew D. Tucker, Daniel Hausrath +62 more

Discovery and Validation of Methylated DNA Markers From Pancreatic Neuroendocrine Tumors

Gastro Hep Advances(2022)10.1016/j.gastha.2022.01.006

N/A

0.104DataRank · unranked

1 citations

Þorvarður R. Hálfdánarson, Calise K. Berger, Patrick H. Foote, Xiaoming Cao, Maria McGlinch +13 more

Predictors of Long-Term Quality of Life for Survivors of Stage II/III Rectal Cancer in the Cancer Care Outcomes Research and Surveillance Consortium

UNC Libraries(2020)10.17615/2v5a-b031

N/A

0DataRank · unranked

0 citations

Robert B. Wallace, Chi Lin, Jennifer A. Schlichting, Jane Pendergast, Grelda Yazmin Juarez +4 more

Bounding box-based 3D AI model for user-guided volumetric segmentation of pancreatic ductal adenocarcinoma on standard-of-care CTs

Pancreatology(2023)10.1016/j.pan.2023.05.008

N/A

0DataRank · unranked

15 citations

Panagiotis Korfiatis, Hala Khasawneh, Naveen Rajamohan, Anurima Patra, Garima Suman +13 more

Efficacy of first‐line checkpoint inhibitors in combination with chemotherapy in high‐grade extrapulmonary metastatic neuroendocrine carcinomas

Journal of Neuroendocrinology(2023)10.1111/jne.13283

N/A

0DataRank · unranked

1 citations

Patrick W. McGarrah, Konstantinos Leventakos, Mohamad Bassam Sonbol, Jason S. Starr, Rachel A. Eiring +3 more

Phase 1/2 trial of vesicular stomatitis virus expressing human interferon-β and NIS (VSV-IFNβ-NIS), with pembrolizumab, in patients with neuroendocrine carcinoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps657

N/A

0DataRank · unranked

6 citations

Shruthi Naik, Þorvarður R. Hálfdánarson, Konstantinos Leventakos, Kah Whye Peng, Stephen J. Russell +3 more

Molecular detection of pancreatic neuroendocrine tumors using methylated DNA markers: Discovery and tissue validation.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e16705

N/A

0DataRank · unranked

0 citations

Calise K. Berger, Patrick H. Foote, Xiaoming Cao, Maria McGlinch, Brianna Gysbers +12 more

1712P Efficacy and safety of cabozantinib (CABO) for advanced lung and thymic neuroendocrine tumors (NET) after progression on prior therapy: Subgroup analysis of phase III CABINET Trial (Alliance A021602)

Annals of Oncology(2025)10.1016/j.annonc.2025.08.2340

N/A

0DataRank · unranked

1 citations

T. Zemla, Susan M. Geyer, Jonathan Strosberg, Þorvarður R. Hálfdánarson, Nikolaos A. Trikalinos +13 more

Consensus guideline for the management of peritoneal metastases from neuroendocrine neoplasms

Cancer(2025)10.1002/cncr.35871

N/A

0DataRank · unranked

1 citations

Leanne Brown, Varun Bansal, Baylee Bakkila, Seth J. Concors, Kiran K. Turaga +9 more

Biomarkers for prognosis in pancreatic neuroendocrine tumors

Endocrine Related Cancer(2021)10.1530/erc-21-0075

N/A

0DataRank · unranked

2 citations

K Sorenson, Rebecca Liu, Bonnie E. Gould Rothberg, Þorvarður R. Hálfdánarson, Mojun Zhu

PET/CT and PET/MRI in neuroendocrine neoplasms

Abdominal Radiology(2022)10.1007/s00261-022-03516-2

N/A

0DataRank · unranked

17 citations

Hala Khasawneh, Aparna Singh, Garima Suman, Geoffrey B. Johnson, Shounak Majumder +3 more

Management recommendations for pancreatic manifestations of von Hippel–Lindau disease

Cancer(2021)10.1002/cncr.33978

N/A

0DataRank · unranked

51 citations

Rachel van Leeuwaarde, Dhaval Patel, Xavier M. Keutgen, Pascal Hammel, Naris Nilubol +5 more

Randomized phase II study of platinum and etoposide (EP) versus temozolomide and capecitabine (CAPTEM) in patients (pts) with advanced G3 non-small cell gastroenteropancreatic neuroendocrine neoplasms (GEPNENs): ECOG-ACRIN EA2142.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4020

N/A

0DataRank · unranked

13 citations

Paul J. Catalano, George A. Fisher, Daniel B. Rubin, Andrei Iagaru, David S. Klimstra +11 more

Þorvarður R. Hálfdánarson

Indexed papers

Top data-sharing exemplar

Papers